Device Trial Radar · NCT04241224
A Prospective, Multicenter Atherectomy Study Showing Luminal Gain in Subjects With Peripheral Vascular Blockages
Last checked: Nov 20, 2026Latest source record: Jan 17, 2023 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
108
Actual
Start
Feb 26, 2020
Primary completion
May 31, 2022
Study completion Nov 17, 2022
Sponsor
- Lead sponsor
- Ra Medical SystemsNot on our public-company list
- Sponsor type
- Industry
- First posted
- Jan 27, 2020
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and effectiveness of the DABRA Laser System in the atherectomy of peripheral vascular stenoses.
Conditions
- Peripheral Arterial Disease
Interventions
AtherectomyDevice
Endovascular treatment of peripheral arterial disease
Primary outcomes
What the sponsor says the trial is designed to measure.
- Technical SuccessTime frame: At Index Procedure
1 more outcomes with a free account
Locations
10 sites in 1 country. Site status is shown where the registry gives one.
California Heart & Vascular Clinic
El Centro, California
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.